269 related articles for article (PubMed ID: 3948766)
1. Acceptor sites on chromatin for receptor bound by estrogen versus antiestrogen in antiestrogen-sensitive and -resistant MCF-7 cells.
Singh RK; Ruh MF; Butler WB; Ruh TS
Endocrinology; 1986 Mar; 118(3):1087-95. PubMed ID: 3948766
[TBL] [Abstract][Full Text] [Related]
2. Antiestrogenic potency and binding characteristics of the triphenylethylene H1285 in MCF-7 human breast cancer cells.
Sheen YY; Ruh TS; Mangel WF; Katzenellenbogen BS
Cancer Res; 1985 Sep; 45(9):4192-9. PubMed ID: 4040807
[TBL] [Abstract][Full Text] [Related]
3. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.
Miller MA; Lippman ME; Katzenellenbogen BS
Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162
[TBL] [Abstract][Full Text] [Related]
4. Binding of [3H]estradiol- and [3H]H1285-receptor complexes to rabbit uterine chromatin.
Singh RK; Ruh MF; Ruh TS
Biochim Biophys Acta; 1984 Jul; 800(1):33-40. PubMed ID: 6743683
[TBL] [Abstract][Full Text] [Related]
5. Tissue and species specificity of unmasked nuclear acceptor sites for the estrogen receptor of Squalus testes.
Ruh MF; Singh RK; Mak P; Callard GV
Endocrinology; 1986 Feb; 118(2):811-8. PubMed ID: 3943492
[TBL] [Abstract][Full Text] [Related]
6. Estrogen and antiestrogen binding to rat uterine and pituitary estrogen receptor: evidence for at least two physicochemical forms of the estrogen receptor.
Jasper TW; Ruh MF; Ruh TS
J Steroid Biochem; 1985 Nov; 23(5A):537-45. PubMed ID: 4079371
[TBL] [Abstract][Full Text] [Related]
7. Interaction of the antiestrogen [3H]H1285 with the two forms of the molybdate-stabilized calf uterine estrogen receptor.
Keene JL; Ruh MF; Ruh TS
J Steroid Biochem; 1984 Dec; 21(6):625-31. PubMed ID: 6527530
[TBL] [Abstract][Full Text] [Related]
8. Relationships between mammary estrogen receptor and estrogenic sensitivity. II. Binding of cytoplasmic receptor to chromatin.
Shyamala G; Singh RK; Ruh MF; Ruh TS
Endocrinology; 1986 Aug; 119(2):819-26. PubMed ID: 3732146
[TBL] [Abstract][Full Text] [Related]
9. Binding of glucocorticoid receptors to mammary chromatin acceptor sites.
Ruh MF; Singh RK; Ruh TS; Shyamala G
J Steroid Biochem; 1987 Dec; 28(6):581-6. PubMed ID: 3695510
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the estrogen receptor and its dynamics in MCF-7 human breast cancer cells using a covalently attaching antiestrogen.
Monsma FJ; Katzenellenbogen BS; Miller MA; Ziegler YS; Katzenellenbogen JA
Endocrinology; 1984 Jul; 115(1):143-53. PubMed ID: 6734512
[TBL] [Abstract][Full Text] [Related]
11. Resistance to tamoxifen with persisting sensitivity to estrogen: possible mediation by excessive antiestrogen binding site activity.
Pavlik EJ; Nelson K; Srinivasan S; Powell DE; Kenady DE; DePriest PD; Gallion HH; van Nagell JR
Cancer Res; 1992 Aug; 52(15):4106-12. PubMed ID: 1638522
[TBL] [Abstract][Full Text] [Related]
12. Interactions of antiestrogens with human breast cancer in long-term tissue culture.
Lippman M; Bolan G; Huff K
Cancer Treat Rep; 1976 Oct; 60(10):1421-9. PubMed ID: 1035504
[TBL] [Abstract][Full Text] [Related]
13. Selection and characterization of a breast cancer cell line resistant to the antiestrogen LY 117018.
Bronzert DA; Greene GL; Lippman ME
Endocrinology; 1985 Oct; 117(4):1409-17. PubMed ID: 4029083
[TBL] [Abstract][Full Text] [Related]
14. Activation of [3H]estradiol--and [3H]H1285-receptor complexes: effect of salt versus ATP on molybdate-stabilized estrogen receptors.
Singh RK; Ruh MF; Ruh TS
J Steroid Biochem; 1984 Aug; 21(2):205-8. PubMed ID: 6482431
[TBL] [Abstract][Full Text] [Related]
15. Estrogen and antiestrogen binding to different forms of the molybdate-stabilized estrogen receptor.
Ruh MF; Brzyski RG; Strange L; Ruh TS
Endocrinology; 1983 Jun; 112(6):2203-5. PubMed ID: 6851947
[TBL] [Abstract][Full Text] [Related]
16. Differences in the form of the salt-transformed estrogen receptor when bound by estrogen versus antiestrogen.
Ruh MF; Turner JW; Paulson CM; Ruh TS
J Steroid Biochem; 1990 Aug; 36(6):509-16. PubMed ID: 2214766
[TBL] [Abstract][Full Text] [Related]
17. Differences between estrogen- and antiestrogen-estrogen receptor complexes from human breast tumors identified with an antibody raised against the estrogen receptor.
Tate AC; Greene GL; DeSombre ER; Jensen EV; Jordan VC
Cancer Res; 1984 Mar; 44(3):1012-8. PubMed ID: 6692388
[TBL] [Abstract][Full Text] [Related]
18. Responses to retinoic acid of tamoxifen-sensitive and -resistant sublines of human breast cancer cell line MCF-7.
Butler WB; Fontana JA
Cancer Res; 1992 Nov; 52(22):6164-7. PubMed ID: 1423259
[TBL] [Abstract][Full Text] [Related]
19. Interaction of the radiolabelled high-affinity anti-oestrogen [3H]H1285 with the cytoplasmic oestrogen receptor.
Keene JL; Sweet F; Ruh MF; Ruh TS
Biochem J; 1984 Feb; 217(3):819-26. PubMed ID: 6712598
[TBL] [Abstract][Full Text] [Related]
20. Induction of two estrogen-responsive proteins by antiestrogens in R27, a tamoxifen-resistant clone of MCF7 cells.
Vignon F; Lippman ME; Nawata H; Derocq D; Rochefort H
Cancer Res; 1984 May; 44(5):2084-8. PubMed ID: 6713400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
